Genomic Diagnostics Co. Veracyte Announces Q2 Financial Results
Total Revenue Increased 166% to $55.1 million; Genomic Volume Grew 215% to 20,856 Tests Company Advanced Clinical Evidence, Pipeline and Global Growth Strategy Raises 2021...
Tag : genomics
Genomic Vision: First-half 2021 Results
H1 2021 sales impacted by the Covid-19 crisis (-24.6% to €467 thousand) Encouraging upturn in activity in Q2, with sales almost doubling vs. Q1 6.2%...
Deep Genomics Raises $180M in Series C Financing
Company expands AI discovery platform for ‘Programmable’ RNA therapeutics and supports advancement of its portfolio into the clinic Oversubscribed round led by SoftBank Vision Fund...
Vizgen, Spatial Genomics Innovator, Expands Leadership Team
Leader in spatially resolved, single-cell transcriptomics appoints Bob Koshgarian as VP of Operations, advancing company towards MERSCOPE™ commercialization Vizgen, the life science company dedicated to...
Element Biosciences Boosts Leadership for DNA Sequencing Platform
Brian Stolz Joins as Chief People Officer, Diana King as VP of Customer Support, and Jordan Neysmith as VP of Engineering Element Biosciences, developer of...
Genomics Co. in dermatology DermTech Announces New San Diego HQ
DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced expansion plans to support...
Kriya Therapeutics Completes $100 Million Series B Financing
Financing led by Patient Square Capital with participation from leading life sciences investors to support the further development of Kriya’s core technology platforms, advancement of...
Genomic Diagnostics Company Veracyte Onboards Rebecca Chambers
Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced the appointment of Rebecca Chambers as executive vice president and chief financial officer. Ms. Chambers,...
Genome-editing Company Caribou Biosciences Doses First Patient
First allogeneic CAR-T cell therapy with a PD-1 knockout in clinical studies Initial data from trial expected in 2022 Caribou Biosciences, Inc., a leading clinical-stage CRISPR...
Genome-editing Focused Life Edit Therapeutics Forms New SAB
Life Edit, an ElevateBio portfolio company, to collaborate with expert scientific advisors to maximize potential of genome-editing platform including novel RNA-guided nucleases and base editors...